KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Goodwill & Intangibles: 2020-2024

Historic Goodwill & Intangibles for AbCellera Biologics (ABCL) over the last 5 years, with Dec 2024 value amounting to $89.9 million.

  • AbCellera Biologics' Goodwill & Intangibles fell 13.21% to $87.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.1 million, marking a year-over-year decrease of 13.21%. This contributed to the annual value of $89.9 million for FY2024, which is 46.55% down from last year.
  • According to the latest figures from FY2024, AbCellera Biologics' Goodwill & Intangibles is $89.9 million, which was down 46.55% from $168.2 million recorded in FY2023.
  • AbCellera Biologics' 5-year Goodwill & Intangibles high stood at $208.8 million for FY2021, and its period low was $89.9 million during FY2024.
  • Over the past 3 years, AbCellera Biologics' median Goodwill & Intangibles value was $168.2 million (recorded in 2023), while the average stood at $145.8 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first surged by 39.96% in 2021, then plummeted by 46.55% in 2024.
  • Over the past 5 years, AbCellera Biologics' Goodwill & Intangibles (Yearly) stood at $149.2 million in 2020, then surged by 39.96% to $208.8 million in 2021, then declined by 14.12% to $179.3 million in 2022, then decreased by 6.18% to $168.2 million in 2023, then slumped by 46.55% to $89.9 million in 2024.